Merck & Co., Inc.
MRK
$79.29
$1.171.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 656.03% | 4,589.59% | 163.63% | 341.53% | -82.30% |
| Total Depreciation and Amortization | 19.10% | 13.75% | 9.09% | 5.69% | 0.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -73.34% | -66.05% | -67.62% | -91.01% | 242.50% |
| Change in Net Operating Assets | -48.20% | -66.30% | 38.13% | 55.03% | 38.33% |
| Cash from Operations | 41.48% | 65.06% | 6.25% | 10.71% | -5.84% |
| Capital Expenditure | -3.28% | 12.71% | 14.89% | 16.58% | 15.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 70.77% | 65.98% | 66.00% | 93.86% | -690.81% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -131.87% | -114.85% | 647.37% | 1,495.54% | 820.56% |
| Cash from Investing | 40.11% | 45.08% | 60.73% | 83.49% | -113.15% |
| Total Debt Issued | -39.40% | -39.40% | -39.40% | -78.99% | -- |
| Total Debt Repaid | -21.32% | 26.50% | 56.99% | 72.57% | -150.00% |
| Issuance of Common Stock | -40.11% | 41.60% | -55.47% | -55.30% | -54.73% |
| Repurchase of Common Stock | -78.01% | 2.97% | -26.97% | -152.98% | -785.23% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.28% | -5.31% | -5.42% | -5.64% | -5.93% |
| Other Financing Activities | -8.92% | -13.41% | 15.27% | 10.63% | -49.08% |
| Cash from Financing | -79.05% | -46.20% | -52.17% | -217.87% | 31.12% |
| Foreign Exchange rate Adjustments | 100.50% | -1,373.91% | 28.08% | -267.31% | 24.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 174.39% | 209.29% | 330.61% | 240.09% | -451.11% |